Get started

Support and Resistance

EURJPY → Retest support before growthFX:EURJPY has been correcting since the opening of the European session. The movement was triggered by yesterday's news related to the trade deal between the US and Europe... EURJPY is reacting to news related to the deal between the US and Europe. A correction is forming amid the fall of the euro, but against the backdrop of the dollar's growth, the currency pair has a chance to rise if the bulls keep the price in the buying zone relative to the support level of 173.08. The dollar is rising, and against this backdrop, the Japanese yen is falling. Bulls have every chance of holding their ground above the previously broken resistance. If the market confirms support, we will have chances for growth. Resistance levels: 173.87 Support levels: 173.082, 172.47 The currency pair may form a liquidity trap relative to the previously broken consolidation resistance. A false breakdown of support and price consolidation in the buying zone (above 173.1) could trigger further growth. Best regards, R. Linda!
Long
by RLinda
8
BTCUSD IS READY TO BREAK THE DESCENDING CHANNELBTCUSD IS READY TO BREAK THE DESCENDING CHANNEL In our latest report we wrote down that the asset may rebound from lower border of the descending channel and head toward local resistance level of 120,000.00. The forecast has successfully worked out, so what's next? Currently the price consolidates slightly below the upper border of the descending channel and local resistance level of 120,000.00. Although, the RSI and MACD confirm bullish impulse and, in general, the asset is in mid-term bullish trend, still would be safer for long trade to wait for a breakout of the resistance with first target of 123,190.30 (ATH).
COINBASE:BTCUSDLong
by ProfessorSingapore
DeGRAM | BNBUSD above the support📊 Technical Analysis ● BNB is climbing a steep micro-channel nested in the long-term purple up-trend; the last dip stopped exactly at the $775 breakout shelf and printed a fresh higher-high, showing buyers still protect every pull-back. ● The old March resistance line has been broken and retested as support; its extension, plus the channel ceiling, converge at $835-840—matching the 1.618 flag-pole projection from July’s consolidation. 💡 Fundamental Analysis ● On-chain activity is surging: Yahoo Finance reports BNB Chain daily transactions and DEX volume just reached multi-month highs, underpinning spot demand. ✨ Summary Long $775-790; hold above the green shelf targets $835 → $840. Invalidate on a 4 h close below $741. ------------------- Share your opinion in the comments and support the idea with a like. Thanks for your support!
Long
by DeGRAM
3
ETHUSD HEADS TOWARDS WEEKLY RESISTANCEETHUSD HEADS TOWARDS WEEKLY RESISTANCE ETHUSD has broken local resistance of 3,850.00 and is currently heading towards weekly resistance of 4,100.00, the level, established in 2021. Last time the asset came close to this level at the end of last year and reversed from it afterwards. Same situation is expected here. Price may retest the level of 3,850.00 and then head towards 4,100.00 level. No reversal signs on RSI or MACD. Vice a versa, RSI shows local strength of the asset, MACD is in the green zone. Buying volume highlights current bullish impulse.
COINBASE:ETHUSDLong
by ProfessorSingapore
DeGRAM | EURGBP exited the channel📊 Technical Analysis ● Breakout: price burst from the July descending wedge, reclaimed 0.8695 former cap, and is now riding a steep intraday channel of higher-highs; the channel mid-line aligns with the broken wedge roof, adding fresh support. ● A pennant is consolidating just above 0.8695; its measured pole and the outer channel top converge at the next horizontal barrier 0.8739. 💡 Fundamental Analysis ● Softer UK July composite-PMI (47.9 vs 50.2 prior) revived BoE cut bets, while ECB speakers flagged “premature to talk easing,” narrowing the rate gap in the euro’s favour. ✨ Summary Long 0.8695-0.8705; pennant break targets 0.8739. Bias void on a 30 m close below 0.8648. ------------------- Share your opinion in the comments and support the idea with like. Thanks for your support!
Long
by DeGRAM
2
Tesla Stock in Bearish Trend - Further Downside ExpectedTesla Stock in Bearish Trend - Further Downside Expected Tesla's (TSLA) stock price continues to display a clear bearish trend structure, characterized by the formation of consistent lower lows and lower highs on the price chart. This technical pattern suggests sustained selling pressure and indicates the downtrend will likely persist in upcoming trading sessions. Key Technical Observations: - Established Downtrend: The consecutive lower highs and lows confirm the bearish price structure remains intact - Weak Momentum: Each rally attempt has failed to gain traction, meeting selling pressure at progressively lower levels - Critical Price Levels: The stock has established well-defined resistance and support zones for traders to monitor Price Projections: - Downside Target at $272: The bearish momentum could drive TSLA toward the $272 support level, representing a potential 15% decline from current levels - Key Resistance at $370: Any recovery attempts will likely face strong selling pressure near the $370 level, which now serves as a major resistance barrier Market Implications: 1. Bearish Continuation Expected: The prevailing trend structure favors further downside unless a significant reversal pattern emerges 2. Breakdown Risk: A decisive move below current support levels could accelerate selling momentum toward $272 3. Short-Term Rally Potential: While the overall trend remains down, temporary rebounds toward $370 may present selling opportunities Trading Considerations: - Short Positions: Consider maintaining bearish exposure while price remains below the $370 resistance level - Stop Loss: A sustained break above $370 would invalidate the immediate bearish outlook - Profit Targets: $272 serves as the primary downside objective, with potential support levels to watch along the way Risk Factors to Monitor: - Market sentiment shifts in the EV sector - Changes in Tesla's production/delivery outlook - Broader market conditions affecting tech/growth stocks The technical setup suggests Tesla shares remain vulnerable to further declines, with $272 emerging as the next significant downside target. Traders should watch for either confirmation of the bearish continuation or potential reversal signals near key support levels. As always, proper risk management remains essential when trading in trending markets.
NASDAQ:TSLAShort
by Brillant_Capital
4
FHE Analysis (4H)A major structure in FHE has turned bearish, and the price is currently pulling back to a fresh and untouched order block. Additionally, the price is trading below supply zones on higher timeframes. A drop toward the specified targets and the green zone is expected, as long as the red box is maintained. A daily candle closing above the invalidation level will invalidate this analysis. For risk management, please don't forget stop loss and capital management When we reach the first target, save some profit and then change the stop to entry Comment if you have any questions Thank You
by behdark
2
My UNH Thesis: Betting on a Healthcare Giant's Come BackThe healthcare sector has been in decline, which creates interesting opportunities. I recently talked about a few pharma plays - Eli Lilly, Novo Nordisk, and Pfizer. Here's why I'm investing in NYSE:UNH : UnitedHealth Group (UNH) has tanked ~50% in the past year, but the July 29 (VERY SOON) earnings could flip the script. As a historically dominant player, UNH is now undervalued amid sector weakness, offering massive upside if regulatory fears ease. Here's my full bull case. 👇 FUNDAMENTAL ANALYSIS Why the Sell-Off? A Perfect Storm of Bad News UNH crushed the market for 15 straight years (2009-2023) with positive returns, predictable EPS growth, and 134% gains over the last decade. But 2024 brought chaos: Feb: Massive cyber attack caused a one-time EPS hit (non-recurring). Ongoing: DOJ antitrust probe, criminal fraud investigation, rising Medicare costs, and Optum losses. April: Disastrous Q1 earnings miss + lowered guidance. Leadership drama: CEO death. This erased gains (down 7% over 5 years), amplified by healthcare sector outflows—the biggest since 2020. But is this overblown? Signs point to yes. The markets almost always overreact to bad news. Bullish Signals: Insiders Betting Big The tide is turning: Insider Buying Boom: $32M+ in 2024 (vs. $6.6M in 2019), including new CEO/CFO—highest in 15 years. Congress Buying: Q2 2024 saw net purchases for the first time in 5 years (vs. historical selling). DOJ Shift: Probe refocusing on pharmacy benefits (PBM) unit, dropping acquisition/monopoly scrutiny—implies no major findings. Great news! Sector Tailwinds: Healthcare is one of 3 S&P sectors below historical valuations. Super investors (usually tech-obsessed) are piling in, despite the sector's -10% YTD vs. S&P's +13%. Plus, UNH's dividend yield is at a record ~3% (vs. 1.5% avg), with 16%+ historical growth and 100%+ free cash flow conversion. Rare combo of yield + growth! Valuation: Screaming Buy? UNH trades at PE ~11.9 (vs. 10-year avg 23)—a steal. Analysts project 16.7% EPS CAGR through 2029. Conservative Scenario: 16.5% EPS growth + PE to 16.5 = $780/share by 2030 (173% total return, 18% CAGR ex-dividends). Optimistic: PE back to 23 = $1,084/share (280% return). Models confirm: DCF (8% FCF growth): ~$484/share (70% upside). DDM (7% div growth): ~$607/share (112% upside). Blended Fair Value: ~$545/share (75-90% upside from ~$300). Buy below $436 for 20% safety margin. Still, there is fear of DOJ uncertainty—investors hate unpredictability and that's why the stock is so low. Key Catalyst: July 29 Earnings This could be UNH's "most important report ever." Watch for: Regulatory/legal updates (DOJ progress). Full-year guidance revisions. Metrics like medical loss ratio and PBM performance. Positive news = potential rocket 🚀. Expectations are low (20 bearish EPS revisions vs. 0 bullish), so a beat could spark volatility... upward. Risks: Not Without Bumps Regulatory escalation (e.g., PBM issues) could tank it further. Short-term headwinds: Medicare costs, sector selling. Mitigants: DOJ de-risking, strong FCF buffer, insider confidence. Enter cautiously—size positions small. TECHNICAL ANALYSIS I also did a little technical analysis: UNH price is at a resistance level My EVaR indicator tells me we are in a low-risk area RSI says the stock is oversold I added the different price targets for better visualization THE PLAN My plan: Later today, I will allocate 1% to 1.5% of my portfolio to the stock. If it drops, I will continue to DCA. The stock is already really beaten down, and I think a company this large cannot drop much more. Quick note: I'm just sharing my journey - not financial advice! 😊
NYSE:UNHLong
by HenriqueCentieiro
31
Bank Nifty Weekly Insights: Key Levels & TrendsBank Nifty ended the week at 56,528.90, registering a marginal gain of +0.44%. 🔹 Key Levels for the Upcoming Week 📌 Price Action Pivot Zone: The critical zone to monitor for potential trend reversals or continuation lies between 56,411 and 56,648. 🔻 Support Levels: Support 1 (S1): 56,055 Support 2 (S2): 55,582 Support 3 (S3): 55,086 🔺 Resistance Levels: Resistance 1 (R1): 57,007 Resistance 2 (R2): 57,484 Resistance 3 (R3): 57,865 📈 Market Outlook ✅ Bullish Scenario: If Bank Nifty sustains above the pivot zone (56,648), it may trigger renewed buying interest, potentially pushing the index toward R1 (57,007) and higher levels like R2 (57,484) and R3 (57,865). ❌ Bearish Scenario: A breakdown below the lower end of the pivot zone at 56,411 may attract selling pressure, dragging the index towards S1 (56,055) and possibly lower levels like S2 (55,582) and S3 (55,086). Disclaimer: lnkd.in
NSE:BANKNIFTY
by ALICEBLUE
ACC - ACC Ltd (Daily chart, NSE) - Long PositionACC - ACC Ltd (Daily chart, NSE) - Long Position Risk assessment: Medium {support structure integrity risk} Risk/Reward ratio ~ 2.75 Current Market Price (CMP) ~ 1848 Entry limit ~ 1845 to 1835 (Avg. - 1840) on July 28, 2025 Target limit ~1950 (+5.98%; +110 points) Stop order limit ~ 1800 (-2.17%; -40 points) Disclaimer: Investments in securities markets are subject to market risks. All information presented in this group is strictly for reference and personal study purposes only and is not a recommendation and/or a solicitation to act upon under any interpretation of the letter. LEGEND: {curly brackets} = observation notes = important updates (parentheses) = information details ~ tilde/approximation = variable value -hyphen = fixed value
NSE:ACCLong
by VEDIMarketWatch